Plan Group Financial’s Boston Scientific BSX Stock Holding History

Plan Group Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,031	Closed	-$378K	–	252
2026 Q1	$378K	Sell	6,031 -1,010	-14%	-$80.8K	0.09%	140
2025 Q4	$671K	Sell	7,041 -1,974	-22%	-$194K	0.17%	105
2025 Q3	$880K	Buy	9,015 +306	+4%	+$31.7K	0.24%	94
2025 Q2	$935K	Buy	8,709 +1,234	+17%	+$125K	0.31%	83
2025 Q1	$754K	Buy	7,475 +3,096	+71%	+$312K	0.27%	75
2024 Q4	$391K	Buy	4,379 +142	+3%	+$12.5K	0.21%	76
2024 Q3	$355K	Buy	+4,237	New	+$334K	0.19%	79
2023 Q3	–	Sell	-3,704	Closed	-$200K	–	76
2023 Q2	$200K	Buy	+3,704	New	+$193K	0.17%	66

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Plan Group Financial's BSX Position: Q2 2026 in Review

Plan Group Financial sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,031 shares — an estimated $378K sold.

Plan Group Financial first reported a position in BSX in Q2 2023 and held it in 8 quarters. The position peaked at $935K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Plan Group Financial reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Plan Group Financial sold 6,031 Boston Scientific shares in Q2 2026, an estimated $378K.
Plan Group Financial first reported a position in Boston Scientific in Q2 2023 and held it in 8 quarters.
Plan Group Financial's Boston Scientific position peaked at $935K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Plan Group Financial's 13F filing for Q2 2026, filed 3 Aug 2026.